Todd Foley - 08 Jun 2023 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Reporting relationship: Director
Issuer ticker: RPTX
Reported as of: 08 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2023, 16:24:02 UTC
Prior SEC filing: 06 Jun 2022
Next SEC filing: 08 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Steve Forte, Attorney-in-Fact

Key filing fact

Todd Foley filed Form 4 for Repare Therapeutics Inc. (RPTX) on 12 Jun 2023.

Key facts

This page summarizes Todd Foley's Form 4 filing for Repare Therapeutics Inc. (RPTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Jun 2023, 16:24.

Change

Previous filing in this sequence was filed on 06 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +27,200
Change %
Price: $0.000000
Shares after: 27,200
Date: 08 Jun 2023
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 27,200
Exercise price: $11.66
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date.